Genpact Q2 Call: ATS Strength and Portfolio Refocus Support Bull Thesis

What happened

Genpact’s Q2 earnings call highlighted 7.1% top-line growth, driven by accelerating Advanced Technology Solutions (ATS) demand, while management announced plans to exit a small set of low‑priority services misaligned with its Agentic Operations strategy. This sharpens the company’s focus on higher‑value, AI‑enabled work and supports the gradual margin expansion narrative outlined in our master report. Paired with strong cash generation and active capital returns, the update is a net positive. However, the market will watch for follow‑through on GenAI pilot conversions and the pace of ATS mix shift to validate the long‑run bull case.

Implication

The Q2 update reinforces our BUY case: accelerating ATS demand and portfolio refinement should support a premium re‑rating as the revenue mix tilts toward technology‑led services. While risks around GenAI scaling and legacy pricing persist, management’s actions signal discipline. Investors should track the revenue disaggregation in the coming quarters to gauge how quickly the shift materializes and sustains above‑market growth.

Thesis delta

No shift. The Q2 call adds conviction: revenue growth remains solid, ATS is accelerating, and the exit from lower‑priority work sharpens the focus on high‑value AI solutions. The long‑run margin and valuation improvement narrative is intact.